Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism MDM2 inhibitors(p53-binding protein Mdm-2 inhibitors), p53 inhibitors(Tumor protein p53 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H46O8 |
InChIKeyIXQKXEUSCPEQRD-DKRGWESNSA-N |
CAS Registry6199-67-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Hyperplasia | Preclinical | China | 28 Aug 2024 |